drug

UX016

1 story · latest Aug 4, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Ultragenyx Pharmaceutical Inc

Timeline

Ultragenyx reports Q2 2026 results, cites two PDUFA dates and Angelman readout ahead

Aug 4Quarterly updateapazunersen rebisufligene etisparvovec

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.